Medical Equipment

Drug Delivery Devices Market Growth Patterns And Forecast Outlook Through 2030

April 10, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Drug Delivery Devices Market During 2026–2030?

The drug delivery devices market has shown strong growth in recent years. It is projected to expand from $95.99 billion in 2025 to $102.15 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.4%. This historical growth can be attributed to the rising prevalence of chronic diseases, expansion of injectable therapies, growth in hospital-based drug administration, increasing use of infusion devices, and advancements in pharmaceutical formulations.

The drug delivery devices market is anticipated to experience robust expansion over the next several years. This sector is projected to reach $128.94 billion by 2030, progressing at a compound annual growth rate (CAGR) of 6.0%. The expansion during this forecast period can be linked to the increasing uptake of home-based drug delivery, greater investments in personalized medicine, the broadening scope of biologics and biosimilars, an escalating demand for connected delivery devices, and the increasing incorporation of digital health platforms. Significant developments expected within the forecast period encompass the rising adoption of smart drug delivery devices, the increased use of self-administration injection systems, a burgeoning demand for controlled release technologies, the growth of wearable drug delivery platforms, and a heightened emphasis on patient-centric designs.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

What Primary Drivers Are Shaping The Drug Delivery Devices Market?

Future expansion of the drug delivery devices market is anticipated to be fueled by rising healthcare expenditure. This expenditure encompasses all financial allocations for health-related services and products, such as costs for hospitals, doctors, nursing, pharmaceutical drugs, and public health initiatives. Several elements contribute to this upward trend, including an aging demographic, the growing occurrence of chronic illnesses, innovations in medical technology, and elevated expenses for medical services and medications. Augmented healthcare investment fosters the advancement of drug delivery devices by supplying increased capital for research, inventive solutions, and the implementation of sophisticated technologies, thereby enhancing treatment effectiveness and patient results. For example, data from the UK’s Office for National Statistics, a government body, indicated that UK healthcare expenditure amounted to approximately $379 billion (£292 billion) in 2023, as reported in May 2024. This reflected a nominal increment of 5.6% when compared to 2022, constituting a substantial acceleration from the 0.9% growth that had been observed in 2023. Consequently, the expanding healthcare expenditure is a primary impetus for the drug delivery devices market’s growth.

Which Segment Classifications Are Used In The Drug Delivery Devices Market Segment Analysis?

The drug delivery devices market covered in this report is segmented –

1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery

2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings

3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

Subsegments:

1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets

2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps

3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders

4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems

5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops

7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films

8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

What Trends Are Affecting The Growth Of The Drug Delivery Devices Market?

Leading firms in the drug delivery devices sector are concentrating on creating sophisticated solutions, including targeted oral release capsules, to boost treatment effectiveness and minimize systemic adverse effects. These capsules are designed to endure the stomach’s acidic conditions, ensuring active ingredients are accurately released in particular areas of the gastrointestinal tract, thereby enhancing bioavailability and localizing therapeutic action. As an example, Evonik, a specialty chemicals and life sciences company based in Germany, introduced its novel EUDRACAP colon capsules in September 2024. These capsules are specifically engineered for the delivery of delicate active substances to the ileo-colonic region. They facilitate the administration of live biotherapeutic products, oral biologics, peptides, proteins, and nucleotides, maintaining their integrity thanks to customized EUDRAGIT coatings. Furthermore, the EUDRACAP colon capsules simplify formulation development due to their ready-to-fill design, accelerating market entry by lessening developmental complexities. This innovation expands Evonik’s existing EUDRACAP platform and reinforces its portfolio of system solutions for advanced oral drug delivery.

Which Firms Are Contributing To The Drug Delivery Devices Market Ecosystem?

Major companies operating in the drug delivery devices market are Becton Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, West Pharmaceutical Services Inc., Gerresheimer AG, Smiths Medical, Elcam Medical, SMC Ltd., Injex, Ypsomed Holding AG, Nemera, H&T Presspart, Syqe Medical, Antares Pharma, Julphar, Teleflex Medical, Kedalion Therapeutics, MediPrint Ophthalmics, Sorrel Medical, Terumo Corporation, Gilero

Get The Full Drug Delivery Devices Market Report:

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Where Is The Drug Delivery Devices Market Primarily Concentrated By Region?

North America was the largest region in the drug delivery devices market in 2025. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Drug Delivery Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=2833&type=smp

Browse Through More Reports Similar to the Global Drug Delivery Devices Market 2026, By The Business Research Company

Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Connected Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/connected-drug-delivery-devices-global-market-report

Pharmaceutical Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795